This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-02-09 CDAMG Conference Call"
Jump to navigation
Jump to search
Lisa Nelson (talk | contribs) |
Lisa Nelson (talk | contribs) |
||
| Line 79: | Line 79: | ||
**SWOT | **SWOT | ||
| − | *** Reviewed the SWOT | + | ***Reviewed the SWOT |
| − | *** Any updates as a result of activity at the WGM? | + | ***Any updates as a result of activity at the WGM? |
| − | *** Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT. | + | ***Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT. |
**Asset List - Status, and ongoing management. | **Asset List - Status, and ongoing management. | ||
***Discuss Status/Development toward CDA Template Interchage Format | ***Discuss Status/Development toward CDA Template Interchage Format | ||
***Discuss Status of CDA Template Registry | ***Discuss Status of CDA Template Registry | ||
**Discuss need for & Development of overall CDA Product Roadmap | **Discuss need for & Development of overall CDA Product Roadmap | ||
| − | **** Roadmap needs to address questions like: | + | ****Roadmap needs to address questions like: |
| − | *** Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use | + | ***Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use |
| − | *** Expectation for CDA R2.0 after CDA R2.1 is released? | + | ***Expectation for CDA R2.0 after CDA R2.1 is released? |
| − | *** What happens to C-CDA if CDA R2.0 is superceeded by R2.1? | + | ***What happens to C-CDA if CDA R2.0 is superceeded by R2.1? |
| − | ** Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean) | + | **Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean) |
| − | *** Review minutes from 2018-01-29. | + | ***Review minutes from 2018-01-29. |
| − | *** Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes? | + | ***Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes? |
| − | ** Discuss Request to add a new member to CMG representing the Quality perspective (Lisa) | + | **Discuss Request to add a new member to CMG representing the Quality perspective (Lisa) |
| − | |||
| − | |||
===Meeting Outcomes=== | ===Meeting Outcomes=== | ||
Revision as of 14:43, 9 February 2018
back to CDA Management Group main page
| HL7 CDAMG Minutes Location: Pelican - Riverside Bldg. |
Date: 2018-02-09 Time: 2:00 PM (ET) | ||
| Facilitator | Brett | Note taker(s) | Lisa |
| Attendee | Name
| ||
| George Dixon | |||
| Jean Duteau | |||
| Rick Geimer | |||
| Kai Heitmann | |||
| Brett Marquard | |||
| Linda Michaelsen | |||
| Dale Nelson | |||
| Lisa Nelson | |||
| Andrew Statler | |||
| Quorum: Chair +3 | |||
Agenda & Minutes
- Welcome
- Agenda review
- Approve Minutes of 2018-01-29_CDAMG_WGM
- Review items
- Discussion Topics
- SWOT
- Reviewed the SWOT
- Any updates as a result of activity at the WGM?
- Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT.
- Asset List - Status, and ongoing management.
- Discuss Status/Development toward CDA Template Interchage Format
- Discuss Status of CDA Template Registry
- Discuss need for & Development of overall CDA Product Roadmap
- Roadmap needs to address questions like:
- Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
- Expectation for CDA R2.0 after CDA R2.1 is released?
- What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
- Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
- Review minutes from 2018-01-29.
- Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
- Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
- SWOT
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved
